JP2013528586A5 - - Google Patents

Download PDF

Info

Publication number
JP2013528586A5
JP2013528586A5 JP2013508577A JP2013508577A JP2013528586A5 JP 2013528586 A5 JP2013528586 A5 JP 2013528586A5 JP 2013508577 A JP2013508577 A JP 2013508577A JP 2013508577 A JP2013508577 A JP 2013508577A JP 2013528586 A5 JP2013528586 A5 JP 2013528586A5
Authority
JP
Japan
Prior art keywords
alkyl
organic peroxide
sample
mono
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013508577A
Other languages
English (en)
Japanese (ja)
Other versions
JP6072677B2 (ja
JP2013528586A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2011/001394 external-priority patent/WO2011138682A2/en
Publication of JP2013528586A publication Critical patent/JP2013528586A/ja
Publication of JP2013528586A5 publication Critical patent/JP2013528586A5/ja
Application granted granted Critical
Publication of JP6072677B2 publication Critical patent/JP6072677B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013508577A 2010-05-06 2011-05-06 微生物の不活化のための有機ペルオキシド化合物 Expired - Fee Related JP6072677B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
US61/395,117 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (3)

Publication Number Publication Date
JP2013528586A JP2013528586A (ja) 2013-07-11
JP2013528586A5 true JP2013528586A5 (https=) 2015-04-16
JP6072677B2 JP6072677B2 (ja) 2017-02-01

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013508577A Expired - Fee Related JP6072677B2 (ja) 2010-05-06 2011-05-06 微生物の不活化のための有機ペルオキシド化合物

Country Status (11)

Country Link
US (1) US9426989B2 (https=)
EP (1) EP2566323A2 (https=)
JP (1) JP6072677B2 (https=)
KR (1) KR20130079398A (https=)
CN (1) CN102946727B (https=)
AU (1) AU2011249487C1 (https=)
BR (1) BR112012028146A2 (https=)
CA (1) CA2796213A1 (https=)
EA (1) EA201291179A1 (https=)
MX (1) MX343948B (https=)
WO (1) WO2011138682A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
MX2022005513A (es) 2019-11-07 2022-06-08 Seqirus Uk Ltd Composiciones y metodos para producir una vacuna viral con tama?o de particula reducido.

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL288026A (https=) * 1963-01-16
US3560395A (en) * 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
DE2933498A1 (de) * 1979-08-18 1981-04-09 Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe Chemothermisches desinfektions- und sterilisationsverfahren
PH25669A (en) * 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) * 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) * 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB9612035D0 (en) * 1996-06-08 1996-08-07 Oilfield Chemical Additives Li Method of inhibiting reservoir souring by bacteria
DE19817743A1 (de) * 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) * 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
TR200200776T2 (tr) 1999-09-24 2002-06-21 Smithkline Beecham Biologicals S.A. Burun içi grip virüsü aşısı.
JP4698112B2 (ja) 2000-03-03 2011-06-08 一般財団法人化学及血清療法研究所 無血清培養かつ浮遊培養可能な細胞及び当該細胞を用いたワクチン用ウイルスの製造法
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) * 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) * 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
ATE503493T1 (de) 2001-02-23 2011-04-15 Glaxosmithkline Biolog Sa Influenza vakzinzusammensetzungen zur intradermaler verabreichung
JP2004536785A (ja) 2001-02-23 2004-12-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
US20030012804A1 (en) * 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
JPWO2003014338A1 (ja) * 2001-08-02 2004-11-25 アンジェスMg株式会社 不活性化ウイルスエンベロープの製造方法
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) * 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) * 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
JP2006523657A (ja) * 2003-04-16 2006-10-19 ネオケミカル デザロージョス アバンサードス,ソシエダ アノニマ 殺生物剤:殺菌剤、防腐剤、消毒剤及び駆虫剤としてのジアルキルケトンペルオキシドの使用
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
NZ551640A (en) 2004-05-20 2010-05-28 Id Biomedical Corp Process for the production of an influenza vaccine
ATE547511T1 (de) 2004-12-23 2012-03-15 Medimmune Llc Nichttumorbildende mdck-zellinie zur vermehrung von viren
GB0505909D0 (en) 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CA2618306C (en) * 2005-08-08 2014-10-21 Oregon Health & Science University Inactivating pathogens with hydrogen peroxide for vaccine production
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
CA2627971A1 (en) 2005-11-01 2007-05-10 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment
ES2286949B1 (es) * 2006-05-26 2008-11-01 Braulio Peña Rodriguez Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
SG177141A1 (en) 2006-12-06 2012-01-30 Novartis Ag Vaccines including antigen from four strains of influenza virus

Similar Documents

Publication Publication Date Title
JP2013528586A5 (https=)
Santry et al. Production and purification of high-titer Newcastle disease virus for use in preclinical mouse models of cancer
CN102181581B (zh) 犬瘟热病毒、肠炎细小病毒和阿留申病毒的三重pcr试剂盒
JP2016185988A5 (https=)
CA2848117A1 (en) Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
CA2796213A1 (en) Organic peroxide compounds for microorganism inactivation
Zhao et al. Enterovirus71 virus‐like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice
JP2012525837A5 (https=)
Ashmi et al. Molecular characterization of canine distemper virus from Tamil Nadu, India
JP2019501640A (ja) Rnaウイルスの採取装置および方法
Morimoto et al. Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity
JP2020503068A5 (https=)
Liao et al. Graphene oxide as a bifunctional material toward superior RNA protection and extraction
EP2716752A1 (en) Canine influenza recombinant virus, preparation method therefor and application thereof
EA201501099A3 (ru) Способ получения катионных амфифильных блок-сополимеров n, n-диметиламиноэтилметакрилата для доставки нуклеиновых кислот в живые клетки
O’Connell et al. Humanized mice for live-attenuated vaccine research: From unmet potential to new promises
PH12023550246A1 (en) Modified chikungunya viruses and sindbis viruses and uses thereof
JP2010507363A5 (https=)
CN102668903B (zh) Dna甲基化修饰剂在调控棉花纤维长度中的应用
CN114990075A (zh) 一株可适用于人用疫苗细胞基质培养的柯萨奇病毒a组10型疫苗株及其应用
JP2016086711A5 (https=)
Soltanialvar et al. Genetic analysis of polymerase complex (PA, PB1 and PB2) genes of H9N2 avian influenza viruses from Iran (1999 to 2009)
CN106978512A (zh) 用于检测新型竹鼠源阿卡斑病毒的rt‑pcr引物及其试剂盒
CN103298936A (zh) 具有新型流感病毒来源的血凝素蛋白基因的重组痘苗病毒